Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 3, 2004, Pages 920-927

  Masunaga, Shin Ichiro ^a   Sakurai, Yoshinori ^a   Suzuki, Minoru ^a   Nagata, Kenji ^a   Maruhashi, Akira ^a   Kinash, Yuko ^a   Ono, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Boron neutron capture therapy; Quiescent cell; Tumor microenvironment; ZD6126

Indexed keywords

CELL SUSPENSIONS; NEUTRON BEAM IRRADIATION; PHARMOKINETICS; VASCULAR TARGETING AGENT;

CELLS; NEUTRON BEAMS; SENSITIVITY ANALYSIS; SPECTROMETRY; TISSUE;

BORON;

4 BORONOPHENYLALANINE; BOROCAPTATE; BROXURIDINE; CYTOCHALASIN B; N ACETYLCOLCHINOL PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CELL LABELING; CELL PROLIFERATION; CELL SURVIVAL; CELL SUSPENSION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GAMMA SPECTROMETRY; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANIMALS; BOROHYDRIDES; BORON; BORON NEUTRON CAPTURE THERAPY; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; ISOTOPES; MICE; MICRONUCLEUS TESTS; ORGANOPHOSPHORUS COMPOUNDS; SULFHYDRYL COMPOUNDS; TUMOR STEM CELL ASSAY;

EID: 4744355086     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.672     Document Type: Article

References (26)

1. J.A. Coderre, G.M. Morris The radiation biology of boron neutron capture therapy Radiat Res 151 1999 1 18
2. J. Denekamp Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy Br J Radiol 66 1993 181 196
3. G. Gastl, T. Hermann, M Steurer Angiogenesis as a target for tumor treatment Oncology 54 1997 177 184
4. D.C. Blakey, S.E. Ashton, F.R Westwood ZD6126: A novel small molecule vascular targeting agent Int J Radiat Oncol Biol Phys 54 2002 1497 1502
5. P.E. Thorpe Vascular targeting agents as cancer therapeutics Clin Cancer Res 10 2004 415 427
6. K. Ono, S. Masunaga, Y Kinashi Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice Jpn J Cancer Res 89 1998 334 340
7. Masunaga S, Ono K, Takahashi A, et al. Impact of p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells. Jpn J Cancer Res 93;1366-1377:2002.
8. D.W. Siemann, A.M. Rojiani Enhancement of radiation therapy by the novel vascular targeting agent ZD6126 Int J Radiat Oncol Biol Phys 53 2002 164 171
9. S. Masunaga, K. Ono, Y Sakurai Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors Int J Radiat Oncol Biol Phys 51 2001 828 839
10. W.R. Horsman, R. Murata Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response Int J Radiat Oncol Biol Phys 57 2003 1047 1055
11. 10B concentrations in tissue for neutron capture therapy by prompt γ-ray spectrometry Nucl Instrum Methods 204 1983 525 531
12. R.S. Caswell, J.J. Coyne, M.L. Randolph Kerma factors for neutron energies below 30 MeV Radiat Res 83 1980 217 254
13. S. Masunaga, K. Ono Significance of the response of quiescent cell populations within solid tumors in cancer therapy J Radiat Res 43 2002 11 25
14. D.C. Blakey, F.R. Westwood, M Walker Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models Clin Cancer Res 8 2002 1974 1983
15. D.E. Goertz, J.L. Yu, R.S Kerbel High-grequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow Cancer Res 62 2002 6371 6375
16. P.D. Davis, G.J. Dougherty, D.C Blakey ZD6126: Novel vascular-targeting agent that causes selective destruction of tumor vasculature Cancer Res 62 2002 7247 7253
17. D.W. Siemann, A.M. Rijiani Antitumor efficacy of conventional anticancer drugs is enhanced by the vascular targeting agent ZD6126 Int J Radiat Oncol Biol Phys 54 2002 1512 1517
18. H. Goto, S. Yano, H Zhang Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice Cancer Res 62 2002 3711 3715
19. Bruns CJ, Koehl G, Kleespies A, et al. Vascular-targeting activity of ZD6126 against primary pancreatic tumour growth and lymph node metastasis following orthotopic tumour cell injection in a nude mouse model. 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2002, Abstract 118.
20. S.R. Wedge, J. Kendrew, D.J Ogilvie Combination of the VEGF receptor tyrosine kinase inhibitor ZD6474 and vascular-targeting agent ZD6126 produces an anti-tumor response Proc Am Assoc Cancer Res 43 2002 1081
21. S. Masunaga, K. Ono, M Suzuki Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: Studies with nicotinamide and hyperthermia Br J Radiol 70; 1997 391 398
22. J.M. Brown, A.J. Giaccia The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy Cancer Res 58 1998 1408 1416
23. P. Vaupel, D.K. Kelleher, M. Hoeckel Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy Semin Oncol 28 Suppl. 8 2001 29 35
24. C. Koumenis, R. Alarcon, E Hammond Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation Mol Cell Biol 21 2001 1297 1310
25. K. Ono, S. Masunaga, Y Kinashi Radiobiological evedence suggesting heterogeneous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapy Int J Radiat Oncol Biol Phys 34 1996 1081 1086
26. S. Masunaga, K. Ono, M. Abe The determination of the hypoxic fraction and clonogenicity of proliferating and quiescent cell populations in murine solid tumors Ann Rep Res Reactor Inst Kyoto Univ 26 1993 69 79